Nifty
:
23518.50
Sensex
:
77578.38
64.70 (0.28%)
239.37 (0.31%)
Nifty
Sensex
:
:
23518.50
77578.38
64.70 (0.28%)
239.37 (0.31%)

Sun Pharmaceutical Industries Ltd.

Pharmaceuticals & Drugs - Global

Rating :
N/A

BSE: 524715 | NSE: SUNPHARMA

NSE BSE
1568.40
05-Jul-2024
  • Open
  • High
  • Low
  • Previous Close
  •  1562.00
  •  1574.75
  •  1557.00
  •  1557.90
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  2481046
  •  38902.16
  •  1960.35
  •  1184.50

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 4,25,929.94
  • 38.53
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 4,18,996.06
  • 0.76%
  • 6.16

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 54.48%
  • 2.10%
  • 5.43%
  • FII
  • DII
  • Others
  • 18.01%
  • 17.16%
  • 2.82%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 5.88
  • 8.11
  • 7.85

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 5.07
  • 12.82
  • 5.23

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 7.76
  • 20.53
  • 42.98

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 38.36
  • 40.24
  • 40.23

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 3.82
  • 4.13
  • 4.88

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 18.09
  • 19.63
  • 21.75

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Net Sales
13,291.39
12,192.41
9.01%
12,652.75
11,940.84
5.96%
11,982.90
10,930.67
9.63%
12,380.70
11,240.97
10.14%
Expenses
9,480.52
9,013.03
5.19%
9,045.13
8,611.11
5.04%
8,947.75
8,128.54
10.08%
9,028.43
8,237.25
9.60%
EBITDA
3,810.87
3,179.38
19.86%
3,607.62
3,329.73
8.35%
3,035.15
2,802.13
8.32%
3,352.27
3,003.72
11.60%
EBIDTM
28.67%
26.08%
28.51%
27.89%
25.33%
25.64%
27.08%
26.72%
Other Income
482.09
293.61
64.19%
532.55
206.48
157.92%
605.94
373.28
62.33%
374.76
173.88
115.53%
Interest
69.17
49.29
40.33%
61.54
80.88
-23.91%
73.57
92.74
-20.67%
34.73
46.18
-24.79%
Depreciation
625.91
632.82
-1.09%
655.13
651.32
0.58%
650.36
671.53
-3.15%
622.14
659.95
-5.73%
PBT
3,597.88
2,790.88
28.92%
3,423.50
2,481.14
37.98%
2,815.52
2,239.69
25.71%
3,000.35
2,471.47
21.40%
Tax
567.21
390.10
45.40%
552.25
468.10
17.98%
148.93
222.91
-33.19%
432.32
283.43
52.53%
PAT
3,030.67
2,400.78
26.24%
2,871.25
2,013.04
42.63%
2,666.59
2,016.78
32.22%
2,568.03
2,188.04
17.37%
PATM
22.80%
19.69%
22.69%
16.86%
22.25%
18.45%
20.74%
19.46%
EPS
12.67
9.90
27.98%
11.82
8.43
40.21%
11.06
8.27
33.74%
10.52
9.03
16.50%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Net Sales
50,307.74
48,496.85
43,885.68
38,654.49
33,498.14
32,837.50
29,065.91
26,415.54
31,308.14
28,108.61
27,392.01
Net Sales Growth
8.64%
10.51%
13.53%
15.39%
2.01%
12.98%
10.03%
-15.63%
11.38%
2.62%
 
Cost Of Goods Sold
10,486.98
10,662.61
10,662.16
10,351.54
8,690.08
9,230.45
7,868.97
7,351.71
8,164.20
6,170.19
6,732.84
Gross Profit
39,820.76
37,834.24
33,223.52
28,302.95
24,808.06
23,607.05
21,196.94
19,063.83
23,143.94
21,938.42
20,659.17
GP Margin
79.15%
78.01%
75.70%
73.22%
74.06%
71.89%
72.93%
72.17%
73.92%
78.05%
75.42%
Total Expenditure
36,501.83
35,747.77
32,298.12
28,772.68
25,030.42
25,863.35
22,792.27
20,880.73
21,625.92
19,950.29
19,615.54
Power & Fuel Cost
-
760.78
830.05
702.78
627.09
621.89
613.60
559.97
525.09
545.44
560.77
% Of Sales
-
1.57%
1.89%
1.82%
1.87%
1.89%
2.11%
2.12%
1.68%
1.94%
2.05%
Employee Cost
-
9,429.06
8,296.03
7,300.83
6,862.23
6,362.35
5,967.09
5,367.05
4,902.30
4,772.31
4,502.64
% Of Sales
-
19.44%
18.90%
18.89%
20.49%
19.38%
20.53%
20.32%
15.66%
16.98%
16.44%
Manufacturing Exp.
-
2,186.62
1,936.77
1,880.71
1,723.78
1,690.00
1,884.71
1,827.40
1,293.98
1,418.59
1,433.89
% Of Sales
-
4.51%
4.41%
4.87%
5.15%
5.15%
6.48%
6.92%
4.13%
5.05%
5.23%
General & Admin Exp.
-
5,252.93
4,256.12
3,270.55
3,179.45
3,340.89
2,729.20
2,862.45
3,113.67
2,956.85
2,894.97
% Of Sales
-
10.83%
9.70%
8.46%
9.49%
10.17%
9.39%
10.84%
9.95%
10.52%
10.57%
Selling & Distn. Exp.
-
5,780.26
5,226.24
4,096.33
3,103.96
3,654.48
2,621.13
1,864.55
2,520.64
2,262.35
2,236.40
% Of Sales
-
11.92%
11.91%
10.60%
9.27%
11.13%
9.02%
7.06%
8.05%
8.05%
8.16%
Miscellaneous Exp.
-
1,675.51
1,090.75
1,169.94
843.83
963.29
1,107.57
1,047.60
1,106.04
1,824.56
2,236.40
% Of Sales
-
3.45%
2.49%
3.03%
2.52%
2.93%
3.81%
3.97%
3.53%
6.49%
4.58%
EBITDA
13,805.91
12,749.08
11,587.56
9,881.81
8,467.72
6,974.15
6,273.64
5,534.81
9,682.22
8,158.32
7,776.47
EBITDA Margin
27.44%
26.29%
26.40%
25.56%
25.28%
21.24%
21.58%
20.95%
30.93%
29.02%
28.39%
Other Income
1,995.34
1,628.24
693.75
1,437.42
859.17
651.59
1,059.44
912.08
1,030.20
658.25
637.89
Interest
239.01
238.47
172.00
127.35
141.43
302.73
555.25
517.57
399.80
523.24
578.99
Depreciation
2,553.54
2,556.64
2,529.43
2,143.74
2,079.95
2,052.78
1,753.25
1,499.84
1,264.75
1,037.53
1,194.72
PBT
12,837.25
11,582.21
9,579.88
9,048.14
7,105.51
5,270.23
5,024.58
4,429.48
9,047.87
7,255.80
6,640.65
Tax
1,700.71
1,439.45
847.59
1,075.50
514.69
822.80
600.88
911.04
1,211.57
913.77
914.69
Tax Rate
13.25%
12.98%
9.01%
24.00%
18.39%
16.42%
15.77%
26.19%
13.39%
13.91%
14.29%
PAT
11,136.54
9,614.79
8,521.48
3,289.27
2,916.15
3,779.76
2,666.88
2,121.14
6,954.44
4,544.26
4,551.94
PAT before Minority Interest
11,073.53
9,648.44
8,560.84
3,405.82
2,284.68
4,186.79
3,209.32
2,567.94
7,836.30
5,656.86
5,488.21
Minority Interest
-63.01
-33.65
-39.36
-116.55
631.47
-407.03
-542.44
-446.80
-881.86
-1,112.60
-936.27
PAT Margin
22.14%
19.83%
19.42%
8.51%
8.71%
11.51%
9.18%
8.03%
22.21%
16.17%
16.62%
PAT Growth
29.21%
12.83%
159.07%
12.79%
-22.85%
41.73%
25.73%
-69.50%
53.04%
-0.17%
 
EPS
46.42
40.07
35.52
13.71
12.15
15.75
11.12
8.84
28.99
18.94
18.97

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Shareholder's Funds
63,666.75
55,995.38
48,011.22
46,462.78
45,264.45
41,409.06
38,314.11
36,639.67
32,982.48
25,638.09
Share Capital
239.93
239.93
239.93
239.93
239.93
239.93
239.93
239.93
240.66
207.12
Total Reserves
63,426.82
55,755.45
47,771.29
46,222.85
45,024.52
41,169.13
38,074.18
36,397.10
32,736.26
25,374.38
Non-Current Liabilities
-2,731.14
-1,997.80
-1,316.37
-1,515.17
246.05
76.72
46.43
599.87
2,169.59
2,335.46
Secured Loans
0.00
0.00
0.00
7.83
6.18
109.47
217.69
185.59
7.73
40.69
Unsecured Loans
1.33
0.00
229.92
646.88
2,022.74
1,413.14
1,554.40
1,250.49
3,102.57
1,327.73
Long Term Provisions
413.89
342.91
369.07
327.12
511.00
430.39
404.46
1,211.11
1,895.86
2,532.34
Current Liabilities
16,983.77
19,906.38
17,208.45
16,145.63
15,706.43
17,339.62
19,864.32
17,887.02
13,143.96
16,146.81
Trade Payables
5,653.30
5,681.52
4,489.76
3,973.66
3,583.64
4,147.87
4,766.20
4,395.39
3,582.92
3,286.54
Other Current Liabilities
2,716.85
2,603.51
2,926.73
4,965.34
2,535.02
1,761.72
1,875.93
2,673.68
1,134.27
2,279.59
Short Term Borrowings
2,844.36
5,958.26
468.52
2,444.90
5,549.38
8,370.76
7,979.70
6,654.92
5,206.12
6,227.92
Short Term Provisions
5,769.26
5,663.09
9,323.44
4,761.73
4,038.39
3,059.27
5,242.49
4,163.03
3,220.65
4,352.76
Total Liabilities
81,358.60
77,224.05
66,958.19
64,110.29
65,077.17
62,138.94
62,109.02
58,917.42
52,381.28
46,971.55
Net Block
23,211.38
24,065.44
22,665.16
21,552.98
22,846.91
21,836.54
18,852.65
17,675.17
15,872.25
12,682.47
Gross Block
44,283.71
43,099.95
38,707.36
35,578.99
35,115.97
31,687.04
26,948.80
24,466.42
22,180.41
20,406.89
Accumulated Depreciation
21,072.33
19,034.51
16,042.20
14,026.01
12,269.06
9,850.50
8,096.15
6,791.25
6,308.16
7,724.42
Non Current Assets
37,884.25
37,341.33
32,093.59
33,668.21
33,423.01
31,069.75
30,473.12
25,963.77
22,439.98
18,055.80
Capital Work in Progress
5,353.88
4,973.16
1,286.80
1,566.83
1,220.34
1,411.15
2,465.16
2,801.38
2,175.45
2,038.61
Non Current Investment
6,441.23
5,451.73
5,214.65
6,482.39
5,245.75
3,951.81
3,052.25
961.00
1,116.07
598.87
Long Term Loans & Adv.
2,784.59
2,757.87
2,880.86
4,061.34
4,104.48
3,848.29
6,052.85
3,844.04
2,322.87
2,631.91
Other Non Current Assets
93.17
93.13
46.12
4.67
5.53
21.96
50.21
682.18
953.34
103.94
Current Assets
43,433.11
39,861.94
34,864.60
30,442.08
31,654.16
31,069.19
31,635.90
32,953.65
29,941.30
28,915.75
Current Investments
8,584.54
9,372.61
7,633.94
3,130.06
4,897.36
3,950.72
4,090.62
230.88
713.81
2,117.43
Inventories
9,868.29
10,513.05
8,925.13
8,997.02
7,874.99
7,885.98
6,880.69
6,832.81
6,422.54
5,667.99
Sundry Debtors
11,249.37
11,438.51
10,484.59
9,061.40
9,421.24
8,884.20
7,815.28
7,202.61
6,775.66
5,106.13
Cash & Bank
10,520.68
5,770.29
5,033.35
6,445.51
6,487.55
7,275.60
9,929.38
15,140.84
13,181.65
10,998.04
Other Current Assets
3,210.23
745.91
775.01
1,319.11
2,973.02
3,072.69
2,919.93
3,546.51
2,847.64
5,026.16
Short Term Loans & Adv.
2,454.24
2,021.57
2,012.58
1,488.98
1,431.54
1,806.39
2,028.62
2,828.26
2,317.13
1,920.52
Net Current Assets
26,449.34
19,955.56
17,656.15
14,296.45
15,947.73
13,729.57
11,771.58
15,066.63
16,797.34
12,768.94
Total Assets
81,317.36
77,203.27
66,958.19
64,110.29
65,077.17
62,138.94
62,109.02
58,917.42
52,381.28
46,971.55

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Cash From Operating Activity
12,134.98
4,959.33
8,984.54
6,170.37
6,554.77
2,196.45
3,907.15
7,082.21
6,685.86
5,615.74
PBT
11,087.89
9,408.43
4,481.32
2,799.37
5,009.59
3,810.20
3,478.98
9,047.87
6,570.63
6,402.90
Adjustment
1,554.40
2,722.56
1,974.95
1,809.85
1,992.54
1,968.66
1,382.22
500.67
1,856.92
773.61
Changes in Working Capital
1,062.13
-5,661.82
1,559.05
2,564.09
898.55
-2,696.00
-212.31
-409.21
246.77
179.59
Cash after chg. in Working capital
13,704.42
6,469.17
8,015.32
7,173.31
7,900.68
3,082.86
4,648.89
9,139.33
8,674.32
7,356.10
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-1,569.44
-1,509.84
969.22
-1,002.94
-1,345.91
-886.41
-741.74
-2,057.12
-1,988.46
-1,740.36
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-690.20
-7,943.68
-5,724.74
536.22
-2,588.84
-681.25
-3,370.81
-4,221.60
-4,371.59
-2,865.74
Net Fixed Assets
-420.26
-573.97
-1,120.95
-8,061.35
-737.44
-543.38
-1,471.92
-1,217.15
2,214.23
-4,631.67
Net Investments
183.27
2,935.63
-11.67
1,824.52
542.39
451.15
978.04
3,038.39
3,504.47
-18,860.43
Others
-453.21
-10,305.34
-4,592.12
6,773.05
-2,393.79
-589.02
-2,876.93
-6,042.84
-10,090.29
20,626.36
Cash from Financing Activity
-6,710.16
2,376.07
-5,193.46
-5,980.48
-5,715.14
-2,730.52
-1,539.26
-2,285.39
-1,888.53
-1,186.53
Net Cash Inflow / Outflow
4,734.62
-608.28
-1,933.66
726.11
-1,749.21
-1,215.32
-1,002.92
575.22
425.74
1,563.47
Opening Cash & Equivalents
4,623.73
4,508.25
6,273.03
5,676.61
7,062.30
7,906.45
8,642.36
8,031.69
7,183.49
4,358.70
Closing Cash & Equivalent
9,285.65
4,623.73
4,508.25
6,273.03
5,676.61
7,062.30
7,906.45
8,642.36
8,031.69
7,285.56

Financial Ratios

Consolidated /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Book Value (Rs.)
265.36
233.38
200.11
193.65
188.66
172.59
159.69
152.70
137.03
123.49
ROA
12.17%
11.88%
5.20%
3.54%
6.58%
5.17%
4.24%
0.00%
11.39%
14.60%
ROE
16.13%
16.46%
7.21%
4.98%
9.66%
8.05%
6.85%
0.00%
19.32%
24.89%
ROCE
17.60%
17.24%
9.28%
5.68%
10.07%
8.68%
8.40%
0.00%
18.64%
25.06%
Fixed Asset Turnover
1.11
1.07
1.81
1.74
1.78
1.92
1.99
1.29
1.34
1.79
Receivable days
85.38
91.17
53.09
54.88
56.22
54.10
53.53
83.25
76.12
48.20
Inventory Days
76.70
80.83
48.68
50.10
48.40
47.84
48.88
78.98
77.46
57.99
Payable days
194.01
174.10
149.21
158.71
152.86
77.81
90.19
85.47
75.24
52.05
Cash Conversion Cycle
-31.93
-2.10
-47.44
-53.73
-48.24
24.13
12.23
76.75
78.34
54.14
Total Debt/Equity
0.04
0.11
0.02
0.08
0.18
0.25
0.27
0.27
0.26
0.35
Interest Cover
47.50
55.70
36.19
20.79
17.55
7.86
7.72
23.63
13.56
12.06

Annual Reports:

FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015

News Update:


  • Sun Pharmaceutical Industries reports 28% rise in Q2 consolidated net profit
    28th Oct 2024, 17:36 PM

    Total consolidated income of the company increased by 9.29% at Rs 13645.39 crore for Q2FY25

    Read More
  • Sun Pharma Inds. - Quarterly Results
    28th Oct 2024, 14:38 PM

    Read More
  • Sun Pharma inks agreement to commercialize Philogen’s specialty product Fibromun
    1st Oct 2024, 10:10 AM

    The two partner companies will share post-commercialization economics in about 45(Philogen):55(Sun Pharma) ratio

    Read More
  • Sun Pharma launches Tedizolid Phosphate tablets in India
    23rd Aug 2024, 16:14 PM

    Tedizolid Phosphate is sold in India under a licensing agreement with Merck Sharp & Dohme Singapore Trading

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.